Working hours: Mon - Fri | 08:00 - 17:00HOTLINE: 0867 95 7568
Technical Article

Preventing white feces from the gut: two new trials feeding beneficial bacteria and metabolites taken from healthy shrimp

A Ningbo University (China) team looked for what healthy shrimp guts have and white-feces guts lack, then fed it back for 14 days before challenge. Four beneficial strains cut deaths from 30.4% to 5.2% (2024); pyruvic acid and glutamine cut them from 45.2% to 12.7% (2026). Results from 50-litre tanks with a Vibrio challenge; no pond trial yet.

Technical articleShrimpNovember 1, 2026
Click to listen to an AI-narrated summary
Full Article
Preventing white feces from the gut: two new trials feeding beneficial bacteria and metabolites taken from healthy shrimp

In short: if white-feces guts lack things that healthy guts have, does feeding them back help shrimp resist white feces? A Ningbo University (China) team tried two ways: four beneficial bacterial strains taken from healthy shrimp guts (published 2024) and two metabolites, pyruvic acid and glutamine (published 2026). Both sharply reduced deaths in whiteleg shrimp challenged with a white-feces Vibrio mix. But these are results from 50-litre tanks, with feeding for 14 days beforehand, no pond trial, and a challenge model without EHP.

30.4% → 5.2%
deaths 14 days after challenge when shrimp were fed four beneficial strains for 14 days beforehand (2024)
45.2% → 12.7%
deaths 9 days after challenge when shrimp were fed pyruvic acid + glutamine for 14 days beforehand (2026)
None yet
published pond trials for either approach

The idea: give the gut back what healthy shrimp have

Part 1 showed that white-feces guts are out of balance: some Vibrio species surge and beneficial bacteria decline. Professor Xiong Jinbo’s group at Ningbo University asked the reverse question: what do healthy shrimp have in the gut that white-feces shrimp lack, and if it is fed back, can shrimp resist white feces?

Three-step diagram: compare healthy and white-feces guts in greenhouse ponds; find what healthy shrimp have and sick ones lack (four strains in 2024, pyruvic acid and glutamine in 2026); feed for 14 days, then challenge with a mix of three Vibrio species
How the two trials were designed (redrawn by Than Vuong from Sha et al. 2024, 2026).

Both trials used the same challenge model: immersing shrimp in a mix of V. fluvialis, V. coralliilyticus and V. tubiashii at 7 : 2 : 1, the ratio found in white-feces guts in the ponds. The team had confirmed that this mix gives healthy shrimp white-feces signs and kills them; the authors themselves say other pathogens cannot be ruled out.

Trial 1 (2024): four beneficial strains

  • Choosing the strains: from gut sequencing data, the team built an interaction network between species and ran simulations to pick the set that best antagonised the three Vibrio. The result was four species isolated from healthy shrimp guts: Ruegeria lacuscaerulensis, Nioella nitratireducens, Bacillus subtilis and Streptomyces euryhalinus, mixed 4 : 3 : 2 : 1.
  • Design: 900 healthy whiteleg post-larvae in 18 tanks of 50 litres, split into three groups: not challenged; challenged only; fed the strains then challenged. The bacteria were mixed into feed at 107 CFU/g feed, fed at 3% of body weight twice a day for 14 days before challenge. The challenge was immersion in the Vibrio mix at 108 CFU/mL, followed for 14 days.
  • Results: after 14 days, 5.2% of the fed group died versus 30.4% of the challenged-only group. The first death in the fed group came on day 7, 4 days later. The unchallenged group lost 10.7%, more than the fed group; the paper does not explain this.
  • In the gut: fewer of the three Vibrio; genes that keep gut-wall cells tightly joined (such as mucins) went up; the gut bacterial network was more stable.
Reading the result correctly: only the four-strain mix was tested in shrimp; there are no data for single strains. The paper also contains two statements that do not quite match: the results say the strains "directly suppressed" the pathogens, while the discussion says they could not directly suppress pathogen growth and protected shrimp by stabilising the gut microbiota and boosting immunity.

Trial 2 (2026): pyruvic acid and glutamine

  • Finding the compounds: gut metabolites were compared between healthy and white-feces shrimp from greenhouse ponds in Ningbo. Pyruvic acid and glutamine were the two "keystone" compounds that dropped in white-feces shrimp; they were combined at 1 : 2, the ratio in healthy guts.
  • Design: 1,440 specific-pathogen-free whiteleg post-larvae, 24 tanks of 50 litres × 60 shrimp, 6 tanks per group, water at 27 °C. Four groups: control; supplement only; supplement then challenge; challenge only. The supplement was fed for 14 days before challenge; immersion in the Vibrio mix at 107 CFU/mL, followed for 9 days.
  • Results: after 9 days, 12.7% of the supplemented group died, close to the unchallenged group (9.6%), versus 45.2% in the challenged-only group. The first death came 2 days later. The hepatopancreas kept its structure and gut villi did not shorten as in the challenged-only group. On day 9, supplemented shrimp were 8.3% heavier than controls.
  • Proposed mechanism: the two compounds boosted three beneficial species (Ruegeria lacuscaerulensis, Bacillus subtilis, Nioella nitratireducens), which kept up levels of lipoxin A4, a compound that damps down inflammation, in the gut and hepatopancreas. Feeding the three-strain community alone (4 : 3 : 2) for 14 days also significantly improved survival after challenge; the exact figures appear only in the paper’s chart.
Mortality chart: 2024 trial not challenged 10.7%, challenged without supplement 30.4%, challenged with four strains 5.2%; 2026 trial not challenged 9.6%, challenged without supplement 45.2%, challenged with pyruvic acid and glutamine 12.7%
Shrimp deaths after the white-feces Vibrio challenge (redrawn by Than Vuong from Sha et al. 2024, 2026).
No dose yet: the paper says shrimp received feed supplemented with pyruvic acid and glutamine, fed at 3% of body weight twice a day, but it does not give the amount of either compound per kg of feed. The authors also note a limitation: the 1 : 2 ratio came from semi-quantitative measurements and needs precise quantification. Farmers should not mix these chemicals into feed themselves.

How far has the evidence got?

Evidence ladder: nothing published yet for grow-out ponds; greenhouse ponds were surveyed to find the differences; 50-litre lab tanks for the four strains and pyruvic acid plus glutamine; test tube for the two metabolites boosting beneficial bacteria
Level of evidence for the two approaches, to November 2026 (compiled by Than Vuong).

A 2026 review of microbiome-based approaches in shrimp farming (probiotics, prebiotics, postbiotics, microbiota transplantation, synthetic communities and more) concludes that the field must move from laboratory efficacy to reproducible farm-scale validation. The Ningbo team also writes that pond trials are the next step.

In practice: what farmers can take from this

  • Prevention, not cure. Both trials fed the supplement for 14 days before challenge. Nothing shows the approach rescues shrimp that already have white feces.
  • The only dose in the papers: beneficial bacteria at 107 CFU/g feed (10 billion CFU per kg of feed), fed continuously for 14 days. That is a tank dose, not a pond dose.
  • The strain matters more than the species name. Bacillus subtilis is in many products, but the effect in the trial came from a set of strains isolated from healthy shrimp guts; nobody has tested B. subtilis alone against white feces. When choosing a probiotic, ask for the strain name, CFU per gram and the registration number.
  • The model is Vibrio, not EHP. Where EHP is endemic, part 1 shows the white strings are mostly EHP spores. A stable gut microbiota does not replace EHP-free post-larvae and careful pond preparation.
  • Keep the gut stable every day: good feed, no overfeeding, pond bottom management, and extra care on hot days and after sudden temperature swings.

Quick questions

Can I buy the four strains used in the trial?

They are strains the research team isolated from healthy shrimp guts; the paper does not mention any commercial product. Bacillus subtilis is in many products, but strains differ, and the effect in the trial came from the four-strain set as a whole.

Should I add pyruvic acid and glutamine to feed myself?

No. The paper does not give the dietary level of either compound, the 1 : 2 ratio still needs precise measurement, and there is no pond trial. There is no dose to apply yet.

Why feed for 14 days beforehand?

In both trials shrimp received the supplement for 14 days before challenge. There are no data for shorter periods, and nothing shows the approach rescues shrimp that already have white feces.

Does this apply to ponds with EHP?

Unknown. Both trials challenged specific-pathogen-free shrimp with three Vibrio species, with no EHP. Where EHP is endemic, white feces is usually linked to heavy EHP, so EHP-free post-larvae and careful pond preparation remain essential.

Sources

  1. Sha H., Lu J., Chen J., Xiong J. Rationally designed probiotics prevent shrimp white feces syndrome via the probiotics–gut microbiome–immunity axis. npj Biofilms Microbiomes 2024;10:40 DOI 10.1038/s41522-024-00509-5. Open access, CC BY.
  2. Sha H., Chen J., He J. et al. Precisely designed keystone metabolites boost shrimp disease resistance by recruiting symbionts via the lipoxin A4-AP-1 pathway. Microbiome 2026;14:168 DOI 10.1186/s40168-026-02418-5. Open access, CC BY-NC-ND.
  3. Imran S., Junejo Y., Ahmad H.I., Ozaslan M., Safdar M. From dysbiosis to resilience: Microbiome engineering for sustainable shrimp aquaculture. Comp Biochem Physiol Part D 2026;61:102024 DOI 10.1016/j.cbd.2026.102024.
  4. Wang Y., Zhang J., Zhou J.Y. et al. Pathological evidence links white feces syndrome in farmed Penaeus vannamei to severe hepatopancreatic Ecytonucleospora hepatopenaei infection in China. J Invertebr Pathol 2026;220:108770 DOI 10.1016/j.jip.2026.108770.
  5. Amin M. et al. Gut microbiota and functional metabolic predictions in white feces disease-infected Pacific white shrimp, Penaeus vannamei, from Indonesian farms. Fish Shellfish Immunol 2025;158:110171 DOI 10.1016/j.fsi.2025.110171.

This article is a synthesis and interpretation by Than Vuong. Numbers come from the original papers (full text or abstract); charts were redrawn by Than Vuong and the papers’ own figures and tables are not reproduced. The "What farmers should know" and "In practice" sections are editorial opinion.

Quick Q&A

Frequently asked questions on this topic

What does "Preventing white feces from the gut: two new trials feeding beneficial bacteria and metabolites taken from healthy shrimp" cover?

A Ningbo University (China) team looked for what healthy shrimp guts have and white-feces guts lack, then fed it back for 14 days before challenge. Four beneficial strains cut deaths from 30.4% to 5.2% (2024); pyruvic acid and glutamine cut them from 45.2% to 12.7% (2026). Results from 50-litre tanks with a Vibrio challenge; no pond trial yet.

Which species does this article apply to?

Shrimp — Vibrio

Related Products

Products linked to this topic

GRO C30
ShrimpThan Vuong Blue

GRO C30

Supplies vitamin C to increase resistance and reduce stress

MIX 400
ShrimpThan Vuong Nutrition

MIX 400

Supply minerals, stabilize alkalinity and pH

AQUA PRO4000X
ShrimpThan Vuong Nutrition

AQUA PRO4000X

Microbial control of algae and harmful bacteria in water

BACWAT New
ShrimpThan Vuong Nutrition

BACWAT New

Comprehensive microbial solution for super-intensive ponds

More Reading

Related technical articles

White feces in whiteleg shrimp: the latest research points to EHP, Vibrio and water temperature
Technical article•Shrimp•November 1, 2026

White feces in whiteleg shrimp: the latest research points to EHP, Vibrio and water temperature

A review of 2021–2026 research: in Chinese outbreaks the white strings were mostly EHP spores; in Indonesia and China some Vibrio sp[...]

Binding and neutralising the Vibrio toxins behind EMS and TPD: clay, antibodies in feed and anti-virulence compounds — how strong is the evidence?
Technical article•Shrimp•October 29, 2026

Binding and neutralising the Vibrio toxins behind EMS and TPD: clay, antibodies in feed and anti-virulence compounds — how strong is the evidence?

A review of 2019–2026 research: montmorillonite clay at 2.5–5 g/kg feed raised whiteleg shrimp survival to 83–94% versus 40% after a[...]

CHANGES IN GUT MICROBIOTA DUE TO GLOBAL WARMING. REGULATING HOST HEALTH AND DISEASE STATUS IN POIKILOTHERMIC ANIMALS
Research Insight•Shrimp•February 28, 2026

CHANGES IN GUT MICROBIOTA DUE TO GLOBAL WARMING. REGULATING HOST HEALTH AND DISEASE STATUS IN POIKILOTHERMIC ANIMALS

Global warming alters the gut microbiota of Pacific whiteleg shrimp by restructuring enterotypes, increasing the risk of diseases su[...]

Ask Than Vuong

Aquaculture technical assistant

Hello there 👋

Describe your pond issue or pick a question below.